Garner, Paul ORCID: 0000-0002-0607-6941, Alejandria, Marissa and Lansang, Mary Ann ORCID: 0000-0002-6606-0466
(2006)
Is DOTS-plus a feasible and cost-effective strategy?
PLoS medicine, 3 (9).
e350-.
PDF
838.pdf - Unspecified Available under License Creative Commons Attribution. Download (191kB) |
Official URL: http://dx.doi.org/10.1371/journal.pmed.0030350
Abstract
Paul Garner and colleagues discuss the implications of the pilot study by Katherine Floyd and colleagues of the DOTS-Plus project for tuberculosis control in the Philippines.
Item Type: | Article |
---|---|
Additional Information: | Published: September 12, 2006. Citation: Garner P, Alejandria M, Lansang MA (2006) Is DOTS-Plus a Feasible and Cost-Effective Strategy? PLoS Med 3(9): e350 doi:10.1371/journal.pmed.0030350 |
Uncontrolled Keywords: | Humans, Tuberculosis, Multidrug-Resistant, Directly Observed Therapy, Feasibility Studies, Cost-Benefit Analysis, World Health Organization |
Subjects: | ?? R1 ?? |
Divisions: | Faculty of Health and Life Sciences |
Depositing User: | Symplectic Admin |
Date Deposited: | 24 Jul 2008 15:44 |
Last Modified: | 16 Mar 2024 13:32 |
DOI: | 10.1371/journal.pmed.0030350 |
Publisher's Statement : | Copyright: © 2006 Garner et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
Related URLs: | |
URI: | https://livrepository.liverpool.ac.uk/id/eprint/838 |